Nicholas S. Downing, MD; Nilay D. Shah, PhD; Jenerius A. Aminawung, MD, MPH; et al.
This study describes withdrawals, boxed warnings, and safety communications affecting pharmaceuticals and biologics approved by the US Food and Drug Administration between 2001 and 2010, and associations between characteristics known at the time of approval and those events.